Recipient
Park View Group Practice
First report 30 Sep 2019•Latest report 30 Sep 2019
Reports, concerns and published responses
Health and care · Healthcare site. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
- Reports
- 1
- Published responses
- 0%
- Concerns addressed
- 0
- Stated actions
- 0
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from Park View Group Practice linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised5
Failure of GPs to recognise the link between the therapy and Pulmonary Fibrosis
Failure to seek early guidance from the prescribing secondary care physician
Failure to refer prescription amendments to the secondary care doctor for medication not started in primary care
CCG classification of the drug as green despite known side effects
Lack of GP awareness of escalation procedures for medication side effects
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026